DNALite Therapeutics
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $7.1M
Investors
- 7
About DNALite Therapeutics
DNALite Therapeutics, Inc.DNALite Therapeutics, Inc. was founded in 2016 and is headquartered in San Francisco, US. The company specializes in developing software solutions for healthcare providers and corporate enterprises. The founders, Mubhij Ahmad and Timothy Day, have prior entrepreneurial experience.DNALite specializes in innovative solutions designed to enhance the efficiency and effectiveness of various industries through its core product offerings. The company focuses on developing advanced analytical tools and software that cater to a diverse client base, including healthcare providers, research institutions, and corporate enterprises. Their flagship product integrates sophisticated data processing capabilities with user-friendly interfaces, allowing clients to streamline their operations and derive actionable insights from complex datasets.DNALite generates revenue primarily through a B2B model, offering subscription-based access to its software solutions. Clients typically engage in annual contracts that provide them with continuous access to product updates, customer support, and training resources. The company's pricing structure accommodates various business sizes, ensuring accessibility for small to large enterprises. In addition to subscriptions, DNALite establishes partnerships with key distributors in targeted markets, facilitating wider reach and enhanced service delivery.As of March 2022, DNALite Therapeutics, Inc. is focusing on launching new products designed to enhance user experience and operational efficiency. The company plans to expand its market presence in Europe and Asia by the end of 2023.60 mn will be utilized to support the development of these new offerings and enhance the company’s marketing strategies to penetrate new geographic areas.
Who invested in DNALite Therapeutics
7 investors across 4 rounds
See all investors in DNALite Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DNALite Therapeutics
Who invested in DNALite Therapeutics?
DNALite Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DNALite Therapeutics raised?
DNALite Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did DNALite Therapeutics last raise money?
DNALite Therapeutics's most recent round on record is a Series A, in Mar 2022.
What does DNALite Therapeutics do?
DNALite Therapeutics is a biotechnology company.
Where is DNALite Therapeutics headquartered?
DNALite Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like DNALite Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DNALite Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DNALite Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.